January 26, 2011
Kottil Rammohan, M.D., professor of neurology and director of the Multiple Sclerosis Center at the University of Miami Miller School of Medicine, discusses Gilenya (fingolimod), a new drug approved by the FDA as a first-line therapy for multiple sclerosis. Dr. Rammohan addresses the efficacy of the drug and whether cost will limit the usage to second-line therapy.
Watch Dr. Rammohan discuss Gilenya »
January 18, 2011
Dr. Walter Bradley, Chairman Emeritus, Department of Neurology, The University of Miami Miller School of Medicine, discusses the new theory on the etiology of Amyotrophic lateral sclerosis (ALS, Lou Gehrig’s Disease) and some new drugs in development that might prolong survival.
Watch Dr. Braldey's two-part video series »
January 11, 2011
Steven E. Lipshultz, M.D.: Professor and Chairman of Pediatrics, University of Miami Miller School of Medicine, Chief of Staff, Holtz Children’s Hospital, discusses therapies for pediatric obesity, including bariatric surgery, diet and exercise, cholesterol lowering agents such as statins, and other topics.
Watch Dr. Lipshultz discuss therapies for pediatric obesity »
January 01, 2011
Lee Kaplan, MD, Chief of Sports medicine at The University of Miami Health System and team doctor for the Miami Hurricanes football team discusses the state-of-the-art methods for surgically repairing torn knee meniscus injuries and for repairing torn ACL’s. Clifton Page, MD, internists for the Miami Hurricanes football team, discusses the new guidelines for handling the return to play for athletes who have suffered a concussion, testing for sickle cell, and for monitoring heat exhaustion.